FDA spars with recalcitrant compounding pharmacy, again

For the third time in 15 months, the FDA is warning healthcare providers and consumers not to use drugs that were made by a Dallas compounder because the medicines may be contaminated. And the ongoing struggle between the agency and NuVision Pharmacy underscores the difficulties that beset the pharmaceutical supply chain despite a recently passed law designed to bolster safety.